-
1
-
-
1442334070
-
Predictors of New-Onset Kidney Disease in a Community-Based Population
-
DOI 10.1001/jama.291.7.844
-
Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291(7):844-850. doi:10.1001/jama.291.7.844 (Pubitemid 38543772)
-
(2004)
Journal of the American Medical Association
, vol.291
, Issue.7
, pp. 844-850
-
-
Fox, C.S.1
Larson, M.G.2
Leip, E.P.3
Culleton, B.4
Wilson, P.W.F.5
Levy, D.6
-
2
-
-
79958811114
-
The definition, classification, and prognosis of chronic kidney disease: A KDIGO controversies conference report
-
doi:10.1038/ki.2010.483
-
Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 80(1):17-28. doi:10.1038/ki.2010.483
-
(2011)
Kidney Int
, vol.80
, Issue.1
, pp. 17-28
-
-
Levey, A.S.1
De Jong, P.E.2
Coresh, J.3
El Nahas, M.4
Astor, B.C.5
Matsushita, K.6
Gansevoort, R.T.7
Kasiske, B.L.8
Eckardt, K.U.9
-
3
-
-
0034700790
-
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
-
Heart Outcomes Prevention Evaluation Study Investigators
-
Heart Outcomes Prevention Evaluation Study Investigators (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355(9200):253-259
-
(2000)
Lancet
, vol.355
, Issue.9200
, pp. 253-259
-
-
-
4
-
-
28044452217
-
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial
-
doi:10.1016/S0140-6736(05)67667-2
-
Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesaniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366(9500):1849-1861. doi:10.1016/S0140-6736(05)67667-2
-
(2005)
Lancet
, vol.366
, Issue.9500
, pp. 1849-1861
-
-
Keech, A.1
Simes, R.J.2
Barter, P.3
Best, J.4
Scott, R.5
Taskinen, M.R.6
Forder, P.7
Pillai, A.8
Davis, T.9
Glasziou, P.10
Drury, P.11
Kesaniemi, Y.A.12
Sullivan, D.13
Hunt, D.14
Colman, P.15
D'Emden, M.16
Whiting, M.17
Ehnholm, C.18
Laakso, M.19
-
5
-
-
0037213037
-
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
-
DOI 10.1046/j.1523-1755.2003.00712.x
-
Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR (2003) Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63(1):225-232. doi:10.1046/j.1523-1755.2003.00712.x (Pubitemid 35463925)
-
(2003)
Kidney International
, vol.63
, Issue.1
, pp. 225-232
-
-
Adler, A.I.1
Stevens, R.J.2
Manley, S.E.3
Bilous, R.W.4
Cull, C.A.5
Holman, R.R.6
-
6
-
-
45149133036
-
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
-
DOI 10.1056/NEJMoa0802987
-
Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358(24):2560-2572. doi:10.1056/NEJMoa0802987 (Pubitemid 351831357)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.24
, pp. 2560-2572
-
-
Patel, A.1
MacMahon, S.2
Chalmers, J.3
Neal, B.4
Billot, L.5
Woodward, M.6
Marre, M.7
Cooper, M.8
Glasziou, P.9
Grobbee, D.10
Hamet, P.11
Harrap, S.12
Heller, S.13
Liu, L.14
Mancia, G.15
Mogensen, C.E.16
Pan, C.17
Poulter, N.18
Rodgers, A.19
Williams, B.20
Bompoint, S.21
De Galan, B.E.22
Joshi, R.23
Travert, F.24
more..
-
7
-
-
77950601556
-
Pathologic classification of diabetic nephropathy
-
doi:10.1681/ASN.2010010010
-
Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E, Joh K, Noel LH, Radhakrishnan J, Seshan SV, Bajema IM, Bruijn JA (2010) Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21(4):556-563. doi:10.1681/ASN.2010010010
-
(2010)
J Am Soc Nephrol
, vol.21
, Issue.4
, pp. 556-563
-
-
Tervaert, T.W.1
Mooyaart, A.L.2
Amann, K.3
Cohen, A.H.4
Cook, H.T.5
Drachenberg, C.B.6
Ferrario, F.7
Fogo, A.B.8
Haas, M.9
De Heer, E.10
Joh, K.11
Noel, L.H.12
Radhakrishnan, J.13
Seshan, S.V.14
Bajema, I.M.15
Bruijn, J.A.16
-
8
-
-
10944263493
-
High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells
-
DOI 10.1111/j.1523-1755.2005.00058.x
-
Mishra R, Emancipator SN, Kern T, Simonson MS (2005) High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int 67(1):82-93. doi:10.1111/j.1523-1755.2005.00058.x (Pubitemid 40019229)
-
(2005)
Kidney International
, vol.67
, Issue.1
, pp. 82-93
-
-
Mishra, R.1
Emancipator, S.N.2
Kern, T.3
Simonson, M.S.4
-
9
-
-
0031959483
-
Effect of glycated proteins on the matrix of glomerular epithelial cells
-
Singh AK, Mo W, Dunea G, Arruda JA (1998) Effect of glycated proteins on the matrix of glomerular epithelial cells. J Am Soc Nephrol 9(5):802-810 (Pubitemid 28209089)
-
(1998)
Journal of the American Society of Nephrology
, vol.9
, Issue.5
, pp. 802-810
-
-
Singh, A.K.1
Mo, W.A.2
Dunea, G.3
Arruda, J.A.L.4
-
10
-
-
0032543872
-
Pathogenesis, prevention, and treatment of diabetic nephropathy
-
doi:10.1016/S0140-6736(98)01346-4
-
Cooper ME (1998) Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352(9123):213-219. doi:10.1016/S0140-6736(98)01346-4
-
(1998)
Lancet
, vol.352
, Issue.9123
, pp. 213-219
-
-
Cooper, M.E.1
-
11
-
-
35948934636
-
Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis
-
DOI 10.1038/nm1667, PII NM1667
-
Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, Corat MA, Zeier M, Blessing E, Oh J, Gerlitz B, Berg DT, Grinnell BW, Chavakis T, Esmon CT, Weiler H, Bierhaus A, Nawroth PP (2007) Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 13(11):1349-1358. doi:10.1038/nm1667 (Pubitemid 350073598)
-
(2007)
Nature Medicine
, vol.13
, Issue.11
, pp. 1349-1358
-
-
Isermann, B.1
Vinnikov, I.A.2
Madhusudhan, T.3
Herzog, S.4
Kashif, M.5
Blautzik, J.6
Corat, M.A.F.7
Zeier, M.8
Blessing, E.9
Oh, J.10
Gerlitz, B.11
Berg, D.T.12
Grinnell, B.W.13
Chavakis, T.14
Esmon, C.T.15
Weiler, H.16
Bierhaus, A.17
Nawroth, P.P.18
-
12
-
-
79956209682
-
Glomerular and tubular damage markers are elevated in patients with diabetes
-
doi:10.2337/dc10-1545
-
Nauta FL, Boertien WE, Bakker SJ, van Goor H, van Oeveren W, de Jong PE, Bilo H, Gansevoort RT (2011) Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 34(4):975-981. doi:10.2337/dc10-1545
-
(2011)
Diabetes Care
, vol.34
, Issue.4
, pp. 975-981
-
-
Nauta, F.L.1
Boertien, W.E.2
Bakker, S.J.3
Van Goor, H.4
Van Oeveren, W.5
De Jong, P.E.6
Bilo, H.7
Gansevoort, R.T.8
-
13
-
-
84865065019
-
Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients
-
doi:10.1016/j.diabres.2012.02.019
-
Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, Kwak IS, Kim YK (2012) Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract 97(2):251-257. doi:10.1016/j.diabres.2012.02.019
-
(2012)
Diabetes Res Clin Pract
, vol.97
, Issue.2
, pp. 251-257
-
-
Kim, S.S.1
Song, S.H.2
Kim, I.J.3
Yang, J.Y.4
Lee, J.G.5
Kwak, I.S.6
Kim, Y.K.7
-
14
-
-
84858291427
-
Clinical impact of albuminuria in diabetic nephropathy
-
doi:10.1007/s10157-011-0508-z
-
Wada T, Shimizu M, Toyama T, Hara A, Kaneko S, Furuichi K (2012) Clinical impact of albuminuria in diabetic nephropathy. Clin Experimental Nephrol 16(1):96-101. doi:10.1007/s10157-011-0508-z
-
(2012)
Clin Experimental Nephrol
, vol.16
, Issue.1
, pp. 96-101
-
-
Wada, T.1
Shimizu, M.2
Toyama, T.3
Hara, A.4
Kaneko, S.5
Furuichi, K.6
-
15
-
-
18044366410
-
Adipokines: Molecular links between obesity and atheroslcerosis
-
doi:10.1152/ajpheart.0 1058.2004
-
Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S (2005) Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 288(5):H2031-H2041. doi:10.1152/ajpheart.0 1058.2004
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.288
, Issue.5
-
-
Lau, D.C.1
Dhillon, B.2
Yan, H.3
Szmitko, P.E.4
Verma, S.5
-
16
-
-
70349101696
-
Urinary adiponectin excretion: A novel marker for vascular damage in type 2 diabetes
-
doi:10.2337/db09-0204
-
von Eynatten M, Liu D, Hock C, Oikonomou D, Baumann M, Allolio B, Korosoglou G, Morcos M, Campean V, Amann K, Lutz J, Heemann U, Nawroth PP, Bierhaus A, Humpert PM (2009) Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes 58(9):2093-2099. doi:10.2337/db09-0204
-
(2009)
Diabetes
, vol.58
, Issue.9
, pp. 2093-2099
-
-
Von Eynatten, M.1
Liu, D.2
Hock, C.3
Oikonomou, D.4
Baumann, M.5
Allolio, B.6
Korosoglou, G.7
Morcos, M.8
Campean, V.9
Amann, K.10
Lutz, J.11
Heemann, U.12
Nawroth, P.P.13
Bierhaus, A.14
Humpert, P.M.15
-
17
-
-
33745834319
-
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
-
DOI 10.1172/JCI29126
-
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116(7):1784-1792. doi:10.1172/JCI29126 (Pubitemid 44033298)
-
(2006)
Journal of Clinical Investigation
, vol.116
, Issue.7
, pp. 1784-1792
-
-
Kadowaki, T.1
Yamauchi, T.2
Kubota, N.3
Hara, K.4
Ueki, K.5
Tobe, K.6
-
18
-
-
84871132740
-
Adiponectin, diabetes and ischemic heart failure: A challenging relationship
-
doi:10.1186/1475-2840-11-151
-
Baldasseroni S, Antenore A, Di Serio C, Orso F, Lonetto G, Bartoli N, Foschini A, Marella A, Pratesi A, Scarantino S, Fumagalli S, Monami M, Mannucci E, Marchionni N, Tarantini F (2012) Adiponectin, diabetes and ischemic heart failure: a challenging relationship. Cardiovasc Diabetol 11:151. doi:10.1186/1475-2840-11-151
-
(2012)
Cardiovasc Diabetol
, vol.11
, pp. 151
-
-
Baldasseroni, S.1
Antenore, A.2
Di Serio, C.3
Orso, F.4
Lonetto, G.5
Bartoli, N.6
Foschini, A.7
Marella, A.8
Pratesi, A.9
Scarantino, S.10
Fumagalli, S.11
Monami, M.12
Mannucci, E.13
Marchionni, N.14
Tarantini, F.15
-
19
-
-
67649409338
-
The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients
-
Ayerden Ebinc F, Ebinc H, Derici U, Aral A, Aybay C, Tacoy G, Koc E, Mutluay R, Altok Reis K, Erten Y, Arinsoy T, Sindel S (2009) The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients. J Nephrol 22(2):216-223
-
(2009)
J Nephrol
, vol.22
, Issue.2
, pp. 216-223
-
-
Ayerden Ebinc, F.1
Ebinc, H.2
Derici, U.3
Aral, A.4
Aybay, C.5
Tacoy, G.6
Koc, E.7
Mutluay, R.8
Altok Reis, K.9
Erten, Y.10
Arinsoy, T.11
Sindel, S.12
-
20
-
-
42449113834
-
Plasma adiponectin complexes have distinct biochemical characteristics
-
DOI 10.1210/en.2007-1561
-
Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE (2008) Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 149(5):2270-2282. doi:10.1210/en.2007-1561 (Pubitemid 351574488)
-
(2008)
Endocrinology
, vol.149
, Issue.5
, pp. 2270-2282
-
-
Schraw, T.1
Wang, Z.V.2
Halberg, N.3
Hawkins, M.4
Scherer, P.E.5
-
21
-
-
24044538551
-
Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner
-
DOI 10.1074/jbc.M501149200
-
Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, Xu A (2005) Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280(18):18341-18347. doi:10.1074/jbc.M501149200 (Pubitemid 41389081)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.18
, pp. 18341-18347
-
-
Wang, Y.1
Lam, K.S.L.2
Xu, J.Y.3
Lu, G.4
Xu, L.Y.5
Cooper, G.J.S.6
Xu, A.7
-
22
-
-
2542523201
-
Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes
-
DOI 10.2337/diabetes.53.6.1621
-
Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, Scherer PE, Hawkins M (2004) Mechanisms of early insulinsensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes 53(6):1621-1629 (Pubitemid 38697679)
-
(2004)
Diabetes
, vol.53
, Issue.6
, pp. 1621-1629
-
-
Tonelli, J.1
Li, W.2
Kishore, P.3
Pajvani, U.B.4
Kwon, E.5
Weaver, C.6
Scherer, P.E.7
Hawkins, M.8
-
23
-
-
38949125405
-
Post-translational modifications of adiponectin: Mechanisms and functional implications
-
DOI 10.1042/BJ20071492
-
Wang Y, Lam KS, Yau MH, Xu A (2008) Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 409(3):623-633. doi:10.1042/BJ20071492 (Pubitemid 351214189)
-
(2008)
Biochemical Journal
, vol.409
, Issue.3
, pp. 623-633
-
-
Wang, Y.1
Lam, K.S.L.2
Yau, M.-H.3
Xu, A.4
-
24
-
-
56349100160
-
Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli
-
doi:10.1007/s10735-008-9198-6
-
Cammisotto PG, Bendayan M (2008) Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli. J Mol Histol 39(6):579-584. doi:10.1007/s10735-008-9198-6
-
(2008)
J Mol Histol
, vol.39
, Issue.6
, pp. 579-584
-
-
Cammisotto, P.G.1
Bendayan, M.2
-
25
-
-
43049095682
-
Adiponectin regulates albuminuria and podocyte function in mice
-
DOI 10.1172/JCI32691
-
Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, Goldstein BJ (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118(5):1645-1656. doi:10.1172/JCI32691 (Pubitemid 351632369)
-
(2008)
Journal of Clinical Investigation
, vol.118
, Issue.5
, pp. 1645-1656
-
-
Sharma, K.1
RamachandraRao, S.2
Qiu, G.3
Usui, H.K.4
Zhu, Y.5
Dunn, S.R.6
Ouedraogo, R.7
Hough, K.8
McCue, P.9
Chan, L.10
Falkner, B.11
Goldstein, B.J.12
-
26
-
-
84858765450
-
Suppression of adiponectin by aberrantly glycosylated IgA1 in glomerular mesangial cells in vitro and in vivo
-
doi:10.1371/journal.pone.0033965
-
Inoue T, Sugiyama H, Kitagawa M, Takiue K, Morinaga H, Ogawa A, Kikumoto Y, Kitamura S, Maeshima Y, Makino H (2012) Suppression of adiponectin by aberrantly glycosylated IgA1 in glomerular mesangial cells in vitro and in vivo. PLoS ONE 7(3):e33965. doi:10.1371/journal.pone.0033965
-
(2012)
PLoS ONE
, vol.7
, Issue.3
-
-
Inoue, T.1
Sugiyama, H.2
Kitagawa, M.3
Takiue, K.4
Morinaga, H.5
Ogawa, A.6
Kikumoto, Y.7
Kitamura, S.8
Maeshima, Y.9
Makino, H.10
-
27
-
-
84873343409
-
Adiponectin promotes functional recovery after podocyte ablation
-
doi:10.1681/ASN.2012040414
-
Rutkowski JM, Wang ZV, Park AS, Zhang J, Zhang D, Hu MC, Moe OW, Susztak K, Scherer PE (2013) Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol 24(2):268-282. doi:10.1681/ASN.2012040414
-
(2013)
J Am Soc Nephrol
, vol.24
, Issue.2
, pp. 268-282
-
-
Rutkowski, J.M.1
Wang, Z.V.2
Park, A.S.3
Zhang, J.4
Zhang, D.5
Hu, M.C.6
Moe, O.W.7
Susztak, K.8
Scherer, P.E.9
-
28
-
-
33845515326
-
Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in european populations: Strongest evidence for association with a variant in the promoter region of the adiponectin gene
-
DOI 10.2337/db06-0271
-
Vionnet N, Tregouet D, Kazeem G, Gut I, Groop PH, Tarnow L, Parving HH, Hadjadj S, Forsblom C, Farrall M, Gauguier D, Cox R, Matsuda F, Heath S, Thevard A, Rousseau R, Cambien F, Marre M, Lathrop M (2006) Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Diabetes 55(11):3166-3174. doi:10.2337/db06-0271 (Pubitemid 44923657)
-
(2006)
Diabetes
, vol.55
, Issue.11
, pp. 3166-3174
-
-
Vionnet, N.1
Tregouet, D.2
Kazeem, G.3
Gut, I.4
Groop, P.-H.5
Tarnow, L.6
Parving, H.-H.7
Hadjadj, S.8
Forsblom, C.9
Farrall, M.10
Gauguier, D.11
Cox, R.12
Matsuda, F.13
Heath, S.14
Thevard, A.15
Rousseau, R.16
Cambien, F.17
Marre, M.18
Lathrop, M.19
-
29
-
-
77954316830
-
Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes
-
doi:10.1093/ndt/gfp771
-
Jaziri R, Aubert R, Roussel R, Emery N, Maimaitiming S, Bellili N, Miot A, Saulnier PJ, Travert F, Hadjadj S, Marre M, Fumeron F, Diabhycar Groups SS (2010) Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes. Nephrol Dial Transplant 25(7):2231-2237. doi:10.1093/ndt/gfp771
-
(2010)
Nephrol Dial Transplant
, vol.25
, Issue.7
, pp. 2231-2237
-
-
Jaziri, R.1
Aubert, R.2
Roussel, R.3
Emery, N.4
Maimaitiming, S.5
Bellili, N.6
Miot, A.7
Saulnier, P.J.8
Travert, F.9
Hadjadj, S.10
Marre, M.11
Fumeron, F.12
Diabhycar Groups, S.S.13
-
30
-
-
0033850165
-
The need for early predictors of diabetic nephropathy risk: Is albumin excretion rate sufficient?
-
Caramori ML, Fioretto P, Mauer M (2000) The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 49(9):1399-1408
-
(2000)
Diabetes
, vol.49
, Issue.9
, pp. 1399-1408
-
-
Caramori, M.L.1
Fioretto, P.2
Mauer, M.3
-
31
-
-
0035458340
-
Does microalbuminuria predict diabetic nephropathy?
-
Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki CM, Herman WH (2001) Does microalbuminuria predict diabetic nephropathy? Diabetes Care 24(9):1560-1566 (Pubitemid 33716449)
-
(2001)
Diabetes Care
, vol.24
, Issue.9
, pp. 1560-1566
-
-
Tabaei, B.P.1
Al-Kassab, A.S.2
Ilag, L.L.3
Zawacki, C.M.4
Herman, W.H.5
-
32
-
-
0034051731
-
Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate
-
Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P (2000) Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 49(3):476-484 (Pubitemid 30131795)
-
(2000)
Diabetes
, vol.49
, Issue.3
, pp. 476-484
-
-
Nosadini, R.1
Velussi, M.2
Brocco, E.3
Bruseghin, M.4
Abaterusso, C.5
Saller, A.6
Dalla, V.M.D.7
Carraro, A.8
Bortoloso, E.9
Sambataro, M.10
Barzon, I.11
Frigato, F.12
Muollo, B.13
Chiesura-Corona, M.14
Pacini, G.15
Baggio, B.16
Piarulli, F.17
Sfriso, A.18
Fioretto, P.19
-
33
-
-
84862080216
-
Sustained effects of a mindfulness-based stress-reduction intervention in type 2 diabetic patients: Design and first results of a randomised controlled trial The Heidelberger Diabetes and Stress-Study
-
May doi:10.2337/dc11-1343
-
Hartmann M, Kopf S, Kircher C, Faude-Lang V, Djuric Z, Augstein F, Friederich HC, Kieser M, Bierhaus A, Humpert PM, Herzog W, Nawroth PP (2012) Sustained effects of a mindfulness-based stress-reduction intervention in type 2 diabetic patients: design and first results of a randomised controlled trial The Heidelberger Diabetes and Stress-Study. Diabetes Care May 35 (5):945-947. doi:10.2337/dc11-1343
-
(2012)
Diabetes Care
, vol.35
, Issue.5
, pp. 945-947
-
-
Hartmann, M.1
Kopf, S.2
Kircher, C.3
Faude-Lang, V.4
Djuric, Z.5
Augstein, F.6
Friederich, H.C.7
Kieser, M.8
Bierhaus, A.9
Humpert, P.M.10
Herzog, W.11
Nawroth, P.P.12
-
35
-
-
65649142017
-
A new equation to estimate glomerular filtration rate
-
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604-612
-
(2009)
Ann Intern Med
, vol.150
, Issue.9
, pp. 604-612
-
-
Levey, A.S.1
Stevens, L.A.2
Schmid, C.H.3
Zhang, Y.L.4
Castro III, A.F.5
Feldman, H.I.6
Kusek, J.W.7
Eggers, P.8
Van Lente, F.9
Greene, T.10
Coresh, J.11
-
36
-
-
84868202394
-
Usefulness of albuminuria as predictor for coronary artery stenosis, regardless of estimated glomerular filtration rate, in patients with type 2 diabetes mellitus
-
doi:10.1016/j.amjcard.2012.07.006
-
Son JW, Jang EH, Kim MK, Kim HL, Baek KH, Song KH, Yoo SJ, Yoon KH, Cha BY, Lee KW, Son HY, Kwon HS (2012) Usefulness of albuminuria as predictor for coronary artery stenosis, regardless of estimated glomerular filtration rate, in patients with type 2 diabetes mellitus. Am J Cardiol 110(10):1434-1439. doi:10.1016/j.amjcard.2012.07.006
-
(2012)
Am J Cardiol
, vol.110
, Issue.10
, pp. 1434-1439
-
-
Son, J.W.1
Jang, E.H.2
Kim, M.K.3
Kim, H.L.4
Baek, K.H.5
Song, K.H.6
Yoo, S.J.7
Yoon, K.H.8
Cha, B.Y.9
Lee, K.W.10
Son, H.Y.11
Kwon, H.S.12
-
37
-
-
4644364657
-
Progression of nephropathy in type 2 diabetic patients
-
DOI 10.1111/j.1523-1755.2004.00925.x
-
Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH (2004) Progression of nephropathy in type 2 diabetic patients. Kidney Int 66(4):1596-1605. doi:10.1111/j.1523-1755.2004.00925.x (Pubitemid 39298395)
-
(2004)
Kidney International
, vol.66
, Issue.4
, pp. 1596-1605
-
-
Rossing, K.1
Christensen, P.K.2
Hovind, P.3
Tarnow, L.4
Rossing, P.5
Parving, H.-H.6
-
38
-
-
84860786143
-
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate
-
Chronic Kidney Disease Prognosis doi:10.1001/jama 2012.3954
-
Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS, Chronic Kidney Disease Prognosis (2012) Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307(18):1941-1951. doi:10.1001/jama 2012.3954
-
(2012)
JAMA
, vol.307
, Issue.18
, pp. 1941-1951
-
-
Matsushita, K.1
Mahmoodi, B.K.2
Woodward, M.3
Emberson, J.R.4
Jafar, T.H.5
Jee, S.H.6
Polkinghorne, K.R.7
Shankar, A.8
Smith, D.H.9
Tonelli, M.10
Warnock, D.G.11
Wen, C.P.12
Coresh, J.13
Gansevoort, R.T.14
Hemmelgarn, B.R.15
Levey, A.S.16
-
39
-
-
10544247316
-
Patterns of renal injury in NIDDM patients with microalbuminuria
-
DOI 10.1007/s001250050616
-
Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G, Nosadini R (1996) Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39(12):1569-1576 (Pubitemid 26397369)
-
(1996)
Diabetologia
, vol.39
, Issue.12
, pp. 1569-1576
-
-
Fioretto, P.1
Mauer, M.2
Brocco, E.3
Velussi, M.4
Frigato, F.5
Muollo, B.6
Sambataro, M.7
Abaterusso, C.8
Baggio, B.9
Crepaldi, G.10
Nosadini, R.11
-
40
-
-
0031029379
-
Podocyte loss and progressive glomerular injury in type II diabetes
-
Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW (1997) Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99(2):342-348. doi:10.1172/JCI119163 (Pubitemid 27053474)
-
(1997)
Journal of Clinical Investigation
, vol.99
, Issue.2
, pp. 342-348
-
-
Pagtalunan, M.E.1
Miller, P.L.2
Jumping-Eagle, S.3
Nelson, R.G.4
Myers, B.D.5
Rennke, H.G.6
Coplon, N.S.7
Sun, L.8
Meyer, T.W.9
-
41
-
-
79959806977
-
Monitoring kidney function and albuminuria in patients with diabetes
-
doi:10.2337/dc11-s247
-
Heerspink HJ, Holtkamp FA, de Zeeuw D, Ravid M (2011) Monitoring kidney function and albuminuria in patients with diabetes. Diabetes Care 34(Suppl 2):S325-S329. doi:10.2337/dc11-s247
-
(2011)
Diabetes Care
, vol.34
, Issue.SUPPL. 2
-
-
Heerspink, H.J.1
Holtkamp, F.A.2
De Zeeuw, D.3
Ravid, M.4
-
42
-
-
7944228052
-
Should albuminuria be a therapeutic target in patients with hypertension and diabetes?
-
quiz A12-14. doi:10.1016/j.amjhyper.2004.08.005
-
de Zeeuw D (2004) Should albuminuria be a therapeutic target in patients with hypertension and diabetes? Am J Hypertens 17 (11 Pt 2):11S-15S; quiz A12-14. doi:10.1016/j.amjhyper.2004.08.005
-
(2004)
Am J Hypertens
, vol.17
, Issue.11 PART 2
-
-
De Zeeuw, D.1
-
43
-
-
84887073603
-
Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetes
-
doi:10.1016/j.jdiacomp.2013.06.008
-
Jorsal A, Petersen EH, Tarnow L, Hess G, Zdunek D, Frystyk J, Flyvbjerg A, Lajer M, Rossing P (2013) Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetes. J Diabetes Complications 27(6):604-608. doi:10.1016/j.jdiacomp.2013.06.008
-
(2013)
J Diabetes Complications
, vol.27
, Issue.6
, pp. 604-608
-
-
Jorsal, A.1
Petersen, E.H.2
Tarnow, L.3
Hess, G.4
Zdunek, D.5
Frystyk, J.6
Flyvbjerg, A.7
Lajer, M.8
Rossing, P.9
-
44
-
-
84884625844
-
Urinary adiponectin concentration is positively associated with micro- and macro-vascular complications
-
doi:10.1186/1475-2840-12-137
-
Jeon WS, Park JW, Lee N, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY, Youn BS (2013) Urinary adiponectin concentration is positively associated with micro- and macro-vascular complications. Cardiovasc Diabetol 12(1):137. doi:10.1186/1475-2840-12-137
-
(2013)
Cardiovasc Diabetol
, vol.12
, Issue.1
, pp. 137
-
-
Jeon, W.S.1
Park, J.W.2
Lee, N.3
Park, S.E.4
Rhee, E.J.5
Lee, W.Y.6
Oh, K.W.7
Park, S.W.8
Park, C.Y.9
Youn, B.S.10
|